Cryosa Completes $8.25 Million in Series A-2 Funding for Further Development of Breakthrough, Minimally Invasive Treatment for Obstructive Sleep Apnea View more
Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman View more
preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment View more
